Italy Probes 11 Deaths in Novartis Flu Vaccine Review
This article is for subscribers only.
Italy’s drug regulator said it’s investigating the deaths of an additional eight people who took Novartis AG’s Fluad influenza vaccine, bringing to 11 the number of fatalities under review.
The eight fatalities include those of people who took doses of two batches of the drug that have been suspended as a precaution, as well as other lots of the vaccine, the Italian Pharmaceutical Agency said in a statement late yesterday.